HYPOTHESIS: A functional vestibular prosthesis can be implanted in human such that electrical stimulation of each semicircular canal produces canal-specific eye movements while preserving vestibular and auditory function. BACKGROUND: A number of vestibular disorders could be treated with prosthetic stimulation of the vestibular end organs. We have previously demonstrated in rhesus monkeys that a vestibular neurostimulator, based on the Nucleus Freedom cochlear implant, can produce canal-specific electrically evoked eye movements while preserving auditory and vestibular function. An investigational device exemption has been obtained from the FDA to study the feasibility of treating uncontrolled Ménière's disease with the device. METHODS: The UW/Nucleus vestibular implant was implanted in the perilymphatic space adjacent to the three semicircular canal ampullae of a human subject with uncontrolled Ménière's disease. Preoperative and postoperative vestibular and auditory function was assessed. Electrically evoked eye movements were measured at 2 time points postoperatively. RESULTS: Implantation of all semicircular canals was technically feasible. Horizontal canal and auditory function were largely, but not totally, lost. Electrode stimulation in 2 of 3 canals resulted in canal-appropriate eye movements. Over time, stimulation thresholds increased. CONCLUSION: Prosthetic implantation of the semicircular canals in humans is technically feasible. Electrical stimulation resulted in canal-specific eye movements, although thresholds increased over time. Preservation of native auditory and vestibular function, previously observed in animals, was not demonstrated in a single subject with advanced Ménière's disease.
HYPOTHESIS: A functional vestibular prosthesis can be implanted in human such that electrical stimulation of each semicircular canal produces canal-specific eye movements while preserving vestibular and auditory function. BACKGROUND: A number of vestibular disorders could be treated with prosthetic stimulation of the vestibular end organs. We have previously demonstrated in rhesus monkeys that a vestibular neurostimulator, based on the Nucleus Freedom cochlear implant, can produce canal-specific electrically evoked eye movements while preserving auditory and vestibular function. An investigational device exemption has been obtained from the FDA to study the feasibility of treating uncontrolled Ménière's disease with the device. METHODS: The UW/Nucleus vestibular implant was implanted in the perilymphatic space adjacent to the three semicircular canal ampullae of a human subject with uncontrolled Ménière's disease. Preoperative and postoperative vestibular and auditory function was assessed. Electrically evoked eye movements were measured at 2 time points postoperatively. RESULTS: Implantation of all semicircular canals was technically feasible. Horizontal canal and auditory function were largely, but not totally, lost. Electrode stimulation in 2 of 3 canals resulted in canal-appropriate eye movements. Over time, stimulation thresholds increased. CONCLUSION: Prosthetic implantation of the semicircular canals in humans is technically feasible. Electrical stimulation resulted in canal-specific eye movements, although thresholds increased over time. Preservation of native auditory and vestibular function, previously observed in animals, was not demonstrated in a single subject with advanced Ménière's disease.
Authors: Steven M Bierer; Leo Ling; Kaibao Nie; Albert F Fuchs; Chris R S Kaneko; Trey Oxford; Amy L Nowack; Sarah J Shepherd; Jay T Rubinstein; James O Phillips Journal: Hear Res Date: 2012-04-05 Impact factor: 3.208
Authors: Chenkai Dai; Gene Y Fridman; Natan S Davidovics; Bryce Chiang; Joong Ho Ahn; Charles C Della Santina Journal: Hear Res Date: 2011-08-26 Impact factor: 3.208
Authors: Abderrahmane Hedjoudje; Russell Hayden; Chenkai Dai; JoongHo Ahn; Mehdi Rahman; Frank Risi; Jiangyang Zhang; Susumu Mori; Charles C Della Santina Journal: J Assoc Res Otolaryngol Date: 2019-06-04
Authors: Christopher Phillips; Sarah J Shepherd; Amy Nowack; Kaibao Nie; Chris R S Kaneko; Jay T Rubinstein; Leo Ling; James O Phillips Journal: J Assoc Res Otolaryngol Date: 2015-10-05
Authors: Daniel Q Sun; Mohamed Lehar; Chenkai Dai; Lani Swarthout; Amanda M Lauer; John P Carey; Diana E Mitchell; Kathleen E Cullen; Charles C Della Santina Journal: J Assoc Res Otolaryngol Date: 2015-03-20
Authors: James O Phillips; Leo Ling; Kaibao Nie; Elyse Jameyson; Christopher M Phillips; Amy L Nowack; Justin S Golub; Jay T Rubinstein Journal: J Neurophysiol Date: 2015-02-04 Impact factor: 2.714
Authors: Christopher Phillips; Leo Ling; Trey Oxford; Amy Nowack; Kaibao Nie; Jay T Rubinstein; James O Phillips Journal: Hear Res Date: 2014-09-22 Impact factor: 3.208
Authors: Peter J Boutros; Desi P Schoo; Mehdi Rahman; Nicolas S Valentin; Margaret R Chow; Andrianna I Ayiotis; Brian J Morris; Andreas Hofner; Aitor Morillo Rascon; Andreas Marx; Ross Deas; Gene Y Fridman; Natan S Davidovics; Bryan K Ward; Carolina Treviño; Stephen P Bowditch; Dale C Roberts; Kelly E Lane; Yoav Gimmon; Michael C Schubert; John P Carey; Andreas Jaeger; Charles C Della Santina Journal: JCI Insight Date: 2019-11-14
Authors: Peter J Boutros; Nicolas S Valentin; Kristin N Hageman; Chenkai Dai; Dale Roberts; Charles C Della Santina Journal: J Neurophysiol Date: 2019-04-17 Impact factor: 2.974
Authors: Kristin N Hageman; Margaret R Chow; Dale Roberts; Peter J Boutros; Angela Tooker; Kye Lee; Sarah Felix; Satinderpall S Pannu; Razi Haque; Charles C Della Santina Journal: J Neurophysiol Date: 2019-11-20 Impact factor: 2.974